Speaker Profile
Gordon J. Freeman

Gordon J. Freeman PhD

Oncology, Medicine
Boston, Massachusetts, United States of America

Connect with the speaker?

Dr. Freeman received his PhD from Harvard University in 1979 and also joined DFCI that year. He did postdoctoral training in the laboratory of Dr. Harvey Cantor and then with Dr. Lee Nadler. Principally involved in basic laboratory research, he has studied the B7-CD28 gene family, showing that B7-2/CD28 is the major costimulatory pathway for T cell activation and that PD-L1/PD-1 is the major coinhibitory pathway for T cell activation.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)